Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice to see some sudden buying, may be some news pending. Fingers crossed :)
All the best,
Knife
maybe news leaked coming next week.....
still a seller trying to put a cap on it, go figure....
Wow, some volume on the ask. This has to get discovered at some point, imo.
They have helped me get better sleep. $SHMN. Can't wait until Sohm gets the recognition it deserves. The gummies, the RX, the ABBIE kit projects, and the high caliber professionals at the helm. Can't wait for $SHMN to capitalize and commercialize. Grateful.
— Dave (@hardlesson1) October 31, 2024
💫 𝐒𝐎𝐇𝐌’𝐬 𝐒𝐮𝐢𝐭𝐞 𝐨𝐟 𝟏𝟑 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐮𝐬 𝐆𝐮𝐦𝐦𝐢𝐞𝐬 💫
— SOHM, Inc. (@sohminc) October 30, 2024
✨ Discover SOHM’s Gummy lineup ✨
Don’t miss out on the chance to elevate your health. Grab your bottle today and experience the delicious way to your wellness journey!
To buy SOHM Gummies, visit Online… pic.twitter.com/NAzAxfGShx
so tell us MP, hows that pos doing now ??
I can't stop laughing...
Hey 0011 stackers we're waiting for you at 0009 and 0008.
If you want out, it's easy, just sell into the bid, right?
2nd Tweet Today:
𝐓𝐡𝐞 𝐖𝐞𝐢𝐫𝐝 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐁𝐞𝐡𝐢𝐧𝐝 𝐒𝐰𝐢𝐭𝐜𝐡𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐆𝐞𝐥𝐚𝐭𝐢𝐧 𝐭𝐨 𝐏𝐞𝐜𝐭𝐢𝐧 𝐢𝐧 𝐆𝐮𝐦𝐦𝐢𝐞𝐬 𝐅𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧
— SOHM, Inc. (@sohminc) October 22, 2024
Ever wondered why some gummies are softer than the others? Well the secret lies in the ingredients!
𝐆𝐞𝐥𝐚𝐭𝐢𝐧 𝐕𝐬…
Me neither, appreciation potential has never been better or more legitimate:
https://www.barchart.com/stocks/quotes/SHMN/interactive-chart
We are thrilled to welcome Dr. David Zarling as our new Senior Product Development in Charge. With his extensive experience and expertise in the field, we are confident that he will significantly contribute to the development of innovative and beneficial products for our company…
— SOHM, Inc. (@sohminc) October 22, 2024
Can't wait until we get the PPS appreciation difference maker! LOL
I think we've just signed our Revenue difference maker:
https://www.linkedin.com/in/davidzarling39/
Dr. David Zarling MA PhD MBA, has multiple experiences as Advisory Board member, Chief Biotechnology, Nutraceutical & Pharmaceutical Advisor At SRI International-BioSciences Division, Pangene Corporation and Colby Pharmaceutical Company, David's initiatives successfully discovered, characterized, developed, partnered or sold novel products and product candidates. His professional management and business skills drive research and product development, alliances and revenue growth through innovative biologic and pharma drug product solutions.
David has a strong background in senior-level professional business, strategic partnering, and product leadership within pharmaceuticals, companion diagnostics, medical devices, healthcare, and biotechnology. He has identified emerging opportunities and strategic partnerships within biotech and pharma leading to significant revenue generation, advancement of innovative product portfolios and approved products. David's experience spans small molecule pharma drugs and synthetic biologics, antibiotics, proteins, nucleic acids, recombinant-gene. - cell-, -exosome- or -liposome-based therapeutics. David functioned in integral roles in development and commercialization of therapeutics products for oncology, immunology, inflammation, infectious and neurodegenerative diseases. David was successful at the University of Vermont, BA with Honors in Biology; Dartmouth College, Department of Biological Sciences, MA, Molecular Biology; Baylor College of Medicine, Department of Virology, PhD, Biochemical Virology and Tumor Virus Drug Development; University of Wisconsin-Medical School, McArdle Lab Cancer Research, Post Doctoral, Tumor Virus Genetics; Pepperdine University, Executive MBA. David held positions at University of Wisconsin Medical School, Department of Pathology, Immunobiology Research Center; Department Molecular Biology, Max Planck Institute for Biophysical Chemistry; University of California-Berkeley, School of Public Health; SRI International Biosciences Division; and as Adjunct Associate Professor of Laboratory Medicine, UCSF
With above addition of Dr. Zarling, other milestones have been achieved in terms of having the right talent with the company for its progress in pharmaceutical, nutraceuticals and biotech areas of the product development, marketing and Sales. Management remains committed to achieving higher revenue growth in 2024 compared to previous years. This includes the revenue from of our new ABBIE kits Mr. Night added.
____
Good grief...the credentials! Baby $shmn at .001 ? My goodness, imo!
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announce-Dr-David-Zarling-Onboard-as-Senior-Product-Development-Advisor?id=456478
https://www.accesswire.com/934202/sohm-inc-announce-dr-david-zarling-onboard-as-senior-product-development-advisor
$shmn SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor https://t.co/h8khwtsQph
— Dave (@hardlesson1) October 22, 2024
Appreciate the update, good to know.
All the best,
Knife
𝐆𝐮𝐦𝐦𝐢𝐞𝐬 𝐕𝐬 𝐏𝐢𝐥𝐥𝐬- 𝐃𝐨 𝐆𝐮𝐦𝐦𝐢𝐞𝐬 𝐑𝐞𝐚𝐥𝐥𝐲 𝐖𝐨𝐫𝐤?
— SOHM, Inc. (@sohminc) October 19, 2024
Tired of swallowing pills for wellness?
Well, say Goodbye to “Pill Fatigue”and enjoy its pleasant alternative– Gummies.
𝐋𝐞𝐭'𝐬 𝐮𝐧𝐥𝐨𝐜𝐤 𝐰𝐡𝐚𝐭 𝐦𝐚𝐤𝐞𝐬 𝐆𝐮𝐦𝐦𝐢𝐞𝐬 𝐏𝐫𝐞𝐟𝐞𝐫𝐚𝐛𝐥𝐞!… pic.twitter.com/TFJ4NhCk8p
Thanks, I haven't yet, but I will in the next few days. tgif, g n' t. :)
thanks for sharing that hl, did you give them a 5 star rating ?
keep low bids in , bashing here and on another board seems to coincide will the sudden ask being stacked and a shrinking bid.
easy to see who is trying so hard to bring the pps down..
Update on Melatonin Gummies, Rose Flavored:
Very impressed. Sleeping much better. Not groggy in the morning.
But aside from the above, which is why I bought them, even more impressive to me is the Flavor/Freshness.
The Rose Flavor is very true, and the individual wrapping is a winner.
They don't melt or stick together in the bottle, and the flavor is preserved. (Important for Retail shipping in hot climates)
This "individual packaging" could be on to something, imo.
This is true:
"Our gummies are made with high-quality ingredients, offering a delicious and healthy treat that stands out due to their unique packaging and flavors. "
Our Amazon sales are going well, and we are excited to share the links to purchase our uniquely packaged gummies and other products at our SOHM Amazon store. Our gummies are made with high-quality ingredients, offering a delicious and healthy treat that stands out due to their…
— SOHM, Inc. (@sohminc) October 15, 2024
I couldn't agree more....
those who like to insult or mock those holding this stock are just misguided children....
I never pump or even recommend buying a stock, but I will share occasionally a stock that I find interesting.,
This stock is building a very interesting story, one brick at a time.
It is a long term play and I will only say look at it yourself and make your own conclusions. A A GC.
prove those trades with a screen shot, thanks....
sounds fishy to me..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175236614
MPstock
Re: gail post# 504
Tuesday, October 15, 2024 11:17:40 PM
Post#
506
of 508
I got in by dumb luck, just happened to see a post on IHub which caught my attention, jumped in at 1.11 5 seconds later it was 1.09 and I thought, ok here we go again.. but then rebound nicely. Unfortunately I didn’t realize any gains today but hopefully tomorrow
lies as usual.....
I was hardly optimistic 4 years ago, SHMN was always a flipping stock until a crew came in and ran it.
It went over .01 for no good reason, something I posted here more than once. Anyone that didn't see the writing on the wall made a big mistake.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159596313
lets do a memory refresh..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162323372
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164163996
So here's some advice MP, don't concern yourself with my trading of this stock, I am happy so far, but expect to be much happier in the near future.
Better get back over to your HOT call before they do another r/s...lol....
not good, don't you have L2 ?
How’s the volume looking over here today?
Myth, you have sounded the same for 4 years. Your optimism has gotten you nowhere, that one run that shmn had will never happen again.
Atleast I was able to make 70% yesterday then get back in low, no opportunity on the stock to do that.
thanks for the laugh MP, so after the reverse split ADTX is trading at 1.14, 5 years ago over 200.00
lol.....
so we can all see where the best buy was back then...
and let me remind you SHMN did run from the mid trips to over a penny when some never took any profit, but hey, it's the stocks fault right ??
lolol...
https://ih.advfn.com/stock-market/NASDAQ/aditxt-ADTX/historical
https://finance.yahoo.com/quote/ADTX/
Maybe yours, mines still alive and well and ready for some big green candles. Good fortune to you. :)
Might even be 4
But let’s be honest, this stock is where Money goes to die.
If you were stuck for 3 years, I don't blame you. :)
I have found that it’s way more fun trading stocks that have a lot of liquidity instead of being stuck for 3 yrs in dead end situations
Awesome Update, and WalMart being added E-Commerce:
Our Amazon sales are going well, and we are excited to share the links to purchase our uniquely packaged gummies and other products at our SOHM Amazon store. Our gummies are made with high-quality ingredients, offering a delicious and healthy treat that stands out due to their…
— SOHM, Inc. (@sohminc) October 15, 2024
Appreciate the response. The point I'm trying to make, is that they MUST Update their Profile every 6 months, or else they would lose their "Verified Profile" status.
I have every confidence they will do it...my point is that it would be a golden opportunity to bolster their Business Description with the new accomplishments.
It costs nothing to do that. It's not "Marketing."
It's Baron sitting down for 20 minutes and updating the Business Description on OTCM.
Something is happening with the way I'm communicating this, that it's not translating. I never imagined I would get this kind of resistance to doing a simple Business Description update, when it's DUE to be done anyway.
Do you guys really want the Business Description to stay Milk Toast the way it is?
No mention of ABBIE, or anything else that's new?
Hmmm, I don't get it. That's it for me on a Monday.
I get what you're saying, and I don't disagree. However, I believe Myth and I are aligned in that this isn't a high value target. There are so many things these guys need to spend their time addressing before they get to a business description in an OTCM profile that virtually nobody actually reads. With such a small organization, resources should be allocated in a manner that drives shareholder value first and foremost...this feels like a nice-to-have, but the marketing "department" (I'm being gracious here) should focus on getting the website fully functional first, finding a way to push more effective public communication second, and update OTCM third (IMHO).
The ABBIE kits are no longer a concept. They have moved from concept, to "Commercialization."
This (and all that is associated with it) should be reflected in the Business Description, imo.
"Dr. David Aguilar, COO, shared that the company has received pre-launch and pre-orders for our ABBIE technology kits. This is significant miles stone for the company and we are very happy to transition from Research and Development to commercialization of GLP ABBIE Technology Kits.
The current CRISPR/Cas9 kits business is expected to grow $ 17.4 billion by year 2032.
This milestone has given us a boost to all our scientist and confidence in our technology and thereby making difference in the pharmaceutical / biotech space.
Our kits are for faster and efficient integration of a chosen genetic sequence into the DNA of a cell including cells of an organism. Our kits significantly reduce the timing of integrating a DNA sequence at a very reduced cost compared to virus or genetic recombination using CRISPR/Cas9. The reduced time also lessens the impact of prolonged experimentation on the environment due to decreased use of materials.
This success encourages all of us and we are so hopeful for our all-pipeline products for our technology and in coming time, we shall share more updates on it including the collaboration with Stanford Medicines."
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-has-Received-ABBIE-Technology-Kits-Pre-Launch-Pre-Orders?id=453974
Many OTC traders are lazy, they won't read Filings/PR, unless:
...they have their interest peaked.
I know what you are saying about ABBIE viability, verifiability, etc.
This is one opportunity to peak their interest.
Appropriately update the Business Description with the realities and accomplishments, and ongoing endeavors, etc.
____
Maybe then they will be motivated to read the filings/PR, and shop at our grocery store.
The current BD is stale, we need some fresh chips n dip.
An updated business description is also free. :)
I totally understand what you want to see here hl, we all do.
I guess what I'm saying, or thinking is when one reads all the past PR's /Tweets etc, especially after Carlsbad was added, the pps has hardly moved at all, and when it did it floated back down. What's it going to take to convince the public this co is for real ?
imo it's sales of Abbie kits/ licenses, with verification of who's buying. Revenues need to reflect that Abbie is a viable product.
In case yopu didn't notice IBN was dropped, imo because of the reason I outlined above.
geez, that should be " hope "..
If you were a grocery store, would you just say?..."We sell Groceries."
Or would you say something that peeks the interest of your shoppers?
I'm not suggesting pump. But we are staying a pharma/biotech, we're not a shell, looking to change.
I'm not saying it's required. But there are so many accomplishments in the last several months.
Let's help the public see them "at-a-glance" through an appropriately updated "Business Description."
_____
Biotech, Carlsbad, CDMO, GMP FDA facility, additions to Advisors, Doctors, Biologists, IP Patent Portfolio, Collaborations with Coastar, Stanford, U of Arizona, launch of Neutraceutical gummies, "A Binding Based Integrating Enzyme" (ABBIE) disruptive technology, etc, etc, insert whatever else is appropriate.
Sohm has reasonable license to write an appropriate Business Description.
Let's update it to reflect what we have here!
It's more than groceries. ")
All imo. respects.
If it were me, I wouldn't bother. The officers/directors are the key piece here; the biz description is pretty basic, and is more important in OTC land when considering how frequently shells change hands in RMs (resulting in an entirely different business model).
Hello hl, I'm not sure the " Business Desciption " is the place to add all of that, imo it should be outlined in the filings but I might be wrong. It isn't required for a " Current " Pink but I also up they keep it updated.
Maybe JD can weigh in on it....where you at JD ??
3) Verified Company Profile. The Company must login to www.otciq.com and verify or update
the information needed to ensure its Company Profile is current and complete in order to
maintain the “Verified Company Profile” designation publicly displayed on
www.otcmarkets.com. Profile information includes, but is not limited to, a complete list of
officers, directors and other insiders, outstanding shares, a business description, and
contact information.
Sohm is almost due for a "Verified Profile" update:
It has to be done every 6 months, and is due in November.
This would be a good time, imo, for the Update to add some substance and progress.
For example, things that could be added might include:
1. Not just Pharma anymore, but to include we're a Biotech, with the CDMO and ABBIE kits.
2. Launch of 13 New Neutraceutical Gummies available for sale on Amazon/ECommerce.
3. Exclusive US Distributor for Stallion Labs, Levitiracetam.
4. Collaborations with Coastar Therapeutics, University of Arizona Center for Innovation, Stanford Medicine.
5. Key Advisors, Doctors, and Biologists added.
6. FDA approved, CDMO, and GMP/Inspected facility in Carlsbad CA.
7. Expanding IP Portfolio, 2 new Patent applications for ABBIE Gene-Editing advancement.
8. New website launched in 2024.
Probably missing some things, but a bunch of the above could be included in the new "Verified Profile" that's almost due. :)
.0012 SHMN
We are pleased to announce that our facility successfully passed an inspection by the California State FDA branch in Mid-September 2024. All our GMP protocols, systems, and equipment met the required standards.
— SOHM, Inc. (@sohminc) October 4, 2024
This achievement allows us to pursue various state wholesale…
Nice to see the Bid size picking up a bit. The Ask remains relatively thin and should crumble easily with any motivated buying.
All the best,
Knife
Followers
|
484
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
66050
|
Created
|
06/10/09
|
Type
|
Free
|
Moderators Myth MDPennyPlayer |
Website: http://www.sohm.com
TWITTER FEED: https://twitter.com/sohminc?lang=en
FACEBOOK FEED: https://www.facebook.com/sohminc/
PRESS RELEASES (SOHM Website): https://www.sohm.com/category/press-releases/
NVSOS: http://nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&nt7=0
NVSOS ACTIONS/AMENDMENTS: http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&CorpName=SOHM%2c+INC.
Contact info.
Phone: (714) 522-6700
Address:
4195 Chino Hills Pkway
Ste 675
Chino Hills, CA 91709
Email: info@sohm.com
SHMN RECENT NEWS
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
https://www.globenewswire.com/news-release/2023/09/26/2749662/0/en/SOHM-Announces-Its-Acquisition-of-ABBIE-a-World-Class-Gene-Editing-Platform-Which-Can-Deliver-Genetic-Payloads-Using-Non-Viral-Vectors.html
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |